Quick Answer
RESMED INC reported Research And Development Expense of $331.28 million for the year ending 2025.
- RESMED INC showed an increase of +7.7% in Research And Development Expense from 2024 to 2025.
- This data is from RESMED INC's annual report (Form 10-K), filed with the SEC on August 8, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2009: $17.91 million | Q4 2009: $19.06 million | Q1 2010: $18.28 million | Q3 2010: $19.74 million | Q4 2010: $21.97 million | Q1 2011: $23.32 million | Q3 2011: $26.21 million | Q4 2011: $27.22 million | Q1 2012: $28.40 million | Q3 2012: $27.22 million | Q4 2012: $30.33 million | Q1 2013: $31.19 million | Q3 2013: $27.36 million | Q4 2013: $29.54 million | Q1 2014: $29.53 million | Q3 2014: $30.02 million | Q4 2014: $29.29 million | Q1 2015: $27.02 million | Q3 2015: $27.19 million | Q4 2015: $28.97 million | Q1 2016: $28.11 million | Q3 2016: $34.45 million | Q4 2016: $38.19 million | Q1 2017: $35.13 million | Q3 2017: $37.42 million | Q4 2017: $40.64 million | Q1 2018: $37.43 million | Q3 2018: $38.79 million | Q4 2018: $43.11 million | Q1 2019: $47.61 million | Q3 2019: $48.03 million | Q4 2019: $49.94 million | Q1 2020: $51.45 million | Q3 2020: $54.53 million | Q4 2020: $54.94 million | Q1 2021: $55.94 million | Q3 2021: $59.95 million | Q4 2021: $62.51 million | Q1 2022: $66.80 million | Q3 2022: $63.19 million | Q4 2022: $69.87 million | Q1 2023: $76.44 million | Q3 2023: $75.71 million | Q4 2023: $73.88 million | Q1 2024: $77.07 million | Q3 2024: $79.52 million | Q4 2024: $81.37 million | Q1 2025: $83.94 million | Q3 2025: $87.32 million | Q4 2025: $90.97 million.
- Over the full 17 years of available data (2009 to 2025), RESMED INC's Research And Development Expense has grown by 425.4%.
- Historical annual values: Fiscal year 2025: $331.28 million | Fiscal year 2024: $307.53 million | Fiscal year 2023: $287.64 million | Fiscal year 2022: $253.58 million | Fiscal year 2021: $225.28 million | Fiscal year 2020: $201.95 million | Fiscal year 2019: $180.65 million | Fiscal year 2018: $155.15 million | Fiscal year 2017: $144.47 million | Fiscal year 2016: $118.65 million | Fiscal year 2015: $114.87 million | Fiscal year 2014: $118.23 million | Fiscal year 2013: $120.12 million | Fiscal year 2012: $109.73 million | Fiscal year 2011: $92.01 million | Fiscal year 2010: $75.20 million | Fiscal year 2009: $63.06 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: